CVS Health (CVS)
(Delayed Data from NYSE)
$58.75 USD
+1.01 (1.75%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $58.89 +0.14 (0.24%) 7:58 PM ET
5-Strong Sell of 5 5
A Value D Growth F Momentum C VGM
Cash flow Statements
Fiscal Year End for CVS Health Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 8,368.00 | 4,165.00 | 7,898.00 | 7,192.00 | 6,631.00 |
Depreciation/Amortization & Depletion | 4,366.00 | 4,247.00 | 4,943.00 | 4,441.00 | 4,371.00 |
Net Change from Assets/Liabilities | 15.00 | 7,003.00 | 3,948.00 | 3,159.00 | 1,499.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 677.00 | 762.00 | 1,476.00 | 1,073.00 | 347.00 |
Net Cash From Operating Activities | 13,426.00 | 16,177.00 | 18,265.00 | 15,865.00 | 12,848.00 |
Property & Equipment | -3,031.00 | -2,727.00 | -2,520.00 | -2,437.00 | -2,457.00 |
Acquisition/ Disposition of Subsidiaries | -16,612.00 | -1,388.00 | -146.00 | -26.00 | -444.00 |
Investments | -1,314.00 | -1,017.00 | -2,717.00 | -3,172.00 | -485.00 |
Other Investing Activities | 68.00 | 85.00 | 122.00 | 101.00 | 47.00 |
Net Cash from Investing Activities | -20,889.00 | -5,047.00 | -5,261.00 | -5,534.00 | -3,339.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1,735.00 | -2,949.00 | 549.00 | 264.00 | 210.00 |
Issuance (Repayment) of Debt | 7,732.00 | -4,211.00 | -9,267.00 | -5,673.00 | -4,600.00 |
Increase (Decrease) Short-Term Debt | 200.00 | 0.00 | 0.00 | 0.00 | -720.00 |
Payment of Dividends & Other Distributions | -3,132.00 | -2,907.00 | -2,625.00 | -2,624.00 | -2,603.00 |
Other Financing Activities | -382.00 | -449.00 | -13.00 | -122.00 | -137.00 |
Net Cash from Financing Activities | 2,683.00 | -10,516.00 | -11,356.00 | -8,155.00 | -7,850.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -4,780.00 | 614.00 | 1,648.00 | 2,176.00 | 1,659.00 |
Cash at Beginning of Period | 13,305.00 | 12,691.00 | 11,043.00 | 5,954.00 | 4,295.00 |
Cash at End of Period | 8,525.00 | 13,305.00 | 12,691.00 | 8,130.00 | 5,954.00 |
Diluted Net EPS | 6.47 | 3.14 | 5.95 | 5.46 | 5.08 |
Fiscal Year End for CVS Health Corporation falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 2,892.00 | 1,124.00 | 8,368.00 | 6,321.00 | 4,056.00 |
Depreciation/Amortization & Depletion | 2,289.00 | 1,138.00 | 4,366.00 | 3,232.00 | 2,105.00 |
Net Change from Assets/Liabilities | 2,882.00 | 2,721.00 | 15.00 | 6,059.00 | 6,791.00 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -71.00 | -80.00 | 677.00 | 450.00 | 394.00 |
Net Cash From Operating Activities | 7,992.00 | 4,903.00 | 13,426.00 | 16,062.00 | 13,346.00 |
Property & Equipment | -1,343.00 | -705.00 | -3,031.00 | -2,120.00 | -1,575.00 |
Acquisition/ Disposition of Subsidiaries | -73.00 | -25.00 | -16,612.00 | -16,492.00 | -16,474.00 |
Investments | -2,363.00 | -1,392.00 | -1,314.00 | -1,078.00 | -859.00 |
Other Investing Activities | 60.00 | 28.00 | 68.00 | 43.00 | 32.00 |
Net Cash from Investing Activities | -3,719.00 | -2,094.00 | -20,889.00 | -19,647.00 | -18,876.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -2,796.00 | -2,824.00 | -1,735.00 | -1,771.00 | -1,896.00 |
Issuance (Repayment) of Debt | 4,922.00 | -18.00 | 7,732.00 | 8,164.00 | 9,111.00 |
Increase (Decrease) Short-Term Debt | -200.00 | 2,519.00 | 200.00 | 0.00 | 1,000.00 |
Payment of Dividends & Other Distributions | -1,698.00 | -840.00 | -3,132.00 | -2,353.00 | -1,574.00 |
Other Financing Activities | -206.00 | -64.00 | -382.00 | -385.00 | -289.00 |
Net Cash from Financing Activities | 22.00 | -1,227.00 | 2,683.00 | 3,655.00 | 6,352.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 4,295.00 | 1,582.00 | -4,780.00 | 70.00 | 822.00 |
Cash at Beginning of Period | 8,525.00 | 8,525.00 | 13,305.00 | 13,305.00 | 13,305.00 |
Cash at End of Period | 12,820.00 | 10,107.00 | 8,525.00 | 13,375.00 | 14,127.00 |
Diluted Net EPS | 1.41 | 0.88 | 1.59 | 1.75 | 1.48 |